Summary of Significant Accounting Policies - Summary of Segment Profit or Loss Including Significant Segment Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Segment Reporting Information, Profit (Loss) [Abstract] | ||||||||
| Collaboration revenue | $ 3,320 | $ 7,874 | $ 4,366 | $ 11,548 | ||||
| Less: | ||||||||
| Compensation and benefits | 7,067 | 14,262 | 15,315 | 30,819 | ||||
| Lab expenses and outside research services | 4,809 | 2,903 | 8,256 | 6,127 | ||||
| Clinical supply costs | 3,028 | 3,873 | 4,407 | 6,947 | ||||
| Clinical trials | 1,371 | 7,081 | 4,755 | 14,094 | ||||
| Support functions | 6,123 | 7,701 | 12,423 | 15,987 | ||||
| Other segment expenses | [1] | 5,315 | 6,192 | 8,522 | 16,407 | |||
| Total operating expenses | 27,713 | 42,012 | 53,678 | 90,381 | ||||
| Loss from operations | (24,393) | (34,138) | (49,312) | (78,833) | ||||
| Other income, net | 1,533 | 3,614 | 3,522 | 7,838 | ||||
| Income tax | 130 | 0 | 130 | 0 | ||||
| Net loss | $ (22,990) | $ (22,930) | $ (30,524) | $ (40,471) | $ (45,920) | $ (70,995) | ||
| ||||||||
| X | ||||||||||
- Definition Clinical supply costs. No definition available.
|
| X | ||||||||||
- Definition Clinical trials. No definition available.
|
| X | ||||||||||
- Definition Lab expenses and outside research services. No definition available.
|
| X | ||||||||||
- Definition Other segment expenses. No definition available.
|
| X | ||||||||||
- Definition Support functions. No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|